The buzzy supplement is beloved by celebrities and starting to show up in skin care. But what can it actually do?

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine ...

Niagen Bioscience can either commercialise the drug candidate independently or sublicense to a strategic pharmaceutical ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Investing.com -- Niagen Bioscience Inc (NASDAQ: NAGE) stock rose 2% after the company announced an exclusive worldwide commercial license agreement with Norway’s Haukeland University Hospital to ...

NanoViricides, Inc. is a publicly traded clinical-stage company focused on creating special purpose nanomaterials for antiviral therapy. The company's innovative nanoviricide class of drug candidates ...

Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using ...

Hedge fund plots takeout of IGM Biosciences, its third Bay Area biotech zombie deal in three months Unlock URL Order Reprints Gift this Article ...

The United States market has experienced a notable uptick, climbing 2.9% in the last week and 14% over the past year, with earnings forecasted to grow by 15% annually. In this favorable environment, ...

SeqOnce Biosciences - Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel By SeqOnce Biosciences, Inc. 24 mins ago SeqOnce Biosciences By SeqOnce Biosciences, Inc.